| Intraperitoneal chemotherapy for women with epithelial ovarian cancer. | |
| | |
MedLine Citation:
|
PMID: 18448554 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In 2006, i.p. chemotherapy re-emerged as a controversial topic in debates about the optimal treatment for women with advanced epithelial ovarian cancer. In this paper, we address the rationale behind i.p. chemotherapy, the data supporting its use, the selection of appropriate patients for i.p. chemotherapy, how best to avoid and manage the toxicities observed with i.p. chemotherapy, and directions for future research. |
| | |
Authors:
|
Edward L Trimble; Sharon Thompson; Michaele C Christian; Lori Minasian |
Related Documents
:
|
1516584 - Results of cyclophosphamide and cisplatin combination chemotherapy in patients with ova... 19015974 - Assessment of ovarian reserve following ovarian tissue banking and/or gnrh-a co-treatme... 6766604 - Retroperitoneal metastases from ovarian carcinoma: reassessment of 365 patients studied... 21166584 - Targeted combined aerosol chemotherapy in dogs and radiologic toxicity grading. 22676354 - Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage... 15492784 - Expression of human kallikrein 7 (hk7/scce) and its inhibitor antileukoprotease (alp/sl... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The oncologist Volume: 13 ISSN: 1083-7159 ISO Abbreviation: Oncologist Publication Date: 2008 Apr |
Date Detail:
|
Created Date: 2008-05-01 Completed Date: 2008-10-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9607837 Medline TA: Oncologist Country: United States |
Other Details:
|
Languages: eng Pagination: 403-9 Citation Subset: IM |
Affiliation:
|
Division of Cancer Treatment and Diagnosis, National Cancer Institute, 6130 Executive Boulevard, Suite 7025, MSC 7436, Bethesda, Maryland 20892-7436, USA. trimblet@ctep.nci.nih.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents
/
administration & dosage,
adverse effects,
therapeutic use* Female Humans Infusions, Parenteral / adverse effects Neoplasms, Glandular and Epithelial / drug therapy*, psychology Ovarian Neoplasms / drug therapy*, psychology Patient Selection Quality of Life Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Chemotherapy in elderly patients with colorectal cancer.
Next Document: Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view.